Differentiation of human SH-SY5Y neuroblastoma cells by all-trans retinoic acid activates the interleukin-18 system

Journal of Interferon and Cytokine Research

Volumn 30, Issue 2, 2010, Pages 55-58

  Sallmon, Hannes ^a   Hoene, Victoria ^a   Weber, Sven C ^a   Dame, Christof ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; NEUROBLASTOMA; RECEPTORS, INTERLEUKIN-18; TRETINOIN;

EID: 77649297417     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0036     Document Type: Article

References (20)

1. Beffert U, Morf ni G, Bock HH, Reyna H, Brady ST, Herz J. 2002. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem 277(51):49958-49964.
2. Bonhomme-Faivre L, Paule B, Urien S, Rudant E, Bottius L, Pradel D, Marrot D. 1996. Pharmacokinetics of all-trans retinoic acid (ATRA) in patients with renal cancer concomitantly treated with interferon alpha 2A (IFN). Int J Pharm 134:99-104.
3. Clagett-Dame M, McNeill EM, Muley PD. 2006. Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J Neurobiol 66(7):739-756.
4. Cuende J, Moreno S, Bolaños J P, Almeida A. 2008. Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuro-blastoma SH-SY5Y differentiation. Oncogene 27(23):3339-3344.
5. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Bührer C, Stahel PF. 2005. IL-18: a key player in neuroinf ammation and neurode-generation? Trends Neurosci 28(9):487-493.
6. Grimmer MR, Weiss WA. 2006. Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr 18(6):634-638.
7. Jeon GS, Park SK, Park SW, Kim DW, Chung CK, Cho SS. 2008. Glial expression of interleukin-18 and its receptor after exci-totoxic damage in the mouse hippocampus. Neurochem Res 33:179-184.
8. Klinz FJ, Yu VC, Sadée W, Costa T. 1987. Differential expression of alpha-subunits of G-proteins in human neuroblastoma-derived cell clones. FEBS Lett 224(1):43-48.
9. Lode HN, Huebener N, Strandsby A, Gaedicke G. 2008. Nutrient mixture including vitamin C, L-lysine, L-proline, and epigal-locatechin is ineffective against tumor growth and metastasis in a syngeneic neuroblastoma model. Pediatr Blood Cancer 50(2):284-288.
10. Maris JM, Hogarty MD, Bagatell R, Cohn SL. 2007. Neuroblastoma. Lancet 369(9579):2106-2120.
11. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E. 2003. Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 18(3):457-472.
12. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB. 1996. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal cortico-genesis, neuronal pathology and perinatal death. Proc Natl Acad Sc i USA 93(20):11173-11178.
13. Ojala JO, Sutinen EM, Salminen A, Pirttilä T. 2008. Interleukin-18 increases expression of kinases involved in tau phosphor-ylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol 205(1-2):86-93.
14. Påhlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T. 1984. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14(2):135-144.
15. Redlinger RE, Jr, Mailliard RB, Lotze MT, Barksdale EM, Jr. 2003. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo. J Pediatr Surg 38:301-307; discussion 301-307.
16. Reinhold A, Zhang J, Gessner R, Felderhoff-Mueser U, Obladen M, Dame C. 2007. High thrombopoietin concentrations in the cere-brospinal f u id of neon ates w it h sepsi s a nd i nt ravent ricula r hemorrhage may contribute to brain damage. J Interferon Cytokine Res 27(2):137-145.
17. Reynolds C P, Matthay KK, Villablanca JG, Maurer BJ. 2003. Retinoid therapy of high-risk neuroblastoma. Cancer Lett 197(1-2):185-192.
18. Sarkar SA, Sharma R P. 2002. Expression of selected apoptosis related genes, MIF, IGIF and TNF alpha, during retinoic acid-induced neural differentiation in murine embryonic stem cells. Cell Struct Funct 27(2):99-107.
19. Wiche G, Briones E, Hirt H, Krepler R, Artlieb U, Denk H. 1983. Differential distribution of microtubule-associated proteins MAP-1 and MAP-2 in neurons of rat brain and association of MAP-1 with microtubules of neuroblastoma cells (clone N2A). EMBO J 2(11):1915-1920.
20. Yoshino O, Osuga Y, Koga K, Tsutsumi O, Yano T, Fujii T, Kugu K, Momoeda M, Fujiwara T, Tomita K, Taketani Y. 2001. Evidence for the expression of interleukin (IL)-18, IL-18 receptor and IL-18 binding protein in the human endometrium. Mol Hum Reprod 7(7):649 - 654.